{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:06:15Z","timestamp":1788815175996,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000296","name":"British Skin Foundation","doi-asserted-by":"publisher","award":["BSF8021"],"award-info":[{"award-number":["BSF8021"]}],"id":[{"id":"10.13039\/501100000296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jaip.2022.09.011","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T13:53:25Z","timestamp":1663854805000},"page":"481-491.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Utility and Safety of Skin Tests in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Systematic Review"],"prefix":"10.1016","volume":"11","author":[{"given":"Ying Xin","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Simon","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Ewa","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Roger","family":"Ardern-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.09.011_bib1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaip.2022.09.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2022.09.011_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking","volume":"36","author":"Walsh","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.13562","article-title":"EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity","volume":"74","author":"Brockow","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.011_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2018.08.052","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms severity score: a useful tool for assessing disease severity and predicting fatal cytomegalovirus disease","volume":"80","author":"Mizukawa","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.145.1.67","article-title":"Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure","volume":"145","author":"Eshki","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib11","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A\u00a0review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.alit.2016.04.001","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS): 11 years retrospective study in Thailand","volume":"65","author":"Hiransuthikul","year":"2016","journal-title":"Allergol"},{"key":"10.1016\/j.jaip.2022.09.011_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/ACI.0000000000000546","article-title":"Making a diagnosis in severe cutaneous drug hypersensitivity reactions","volume":"19","author":"Ardern-Jones","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib15","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","article-title":"Skin testing and patch testing in non-IgE-mediated drug allergy","volume":"14","author":"Barbaud","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2022.09.011_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A\u00a0multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cod.14090","article-title":"Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): a literature review","volume":"86","author":"de Groot","year":"2022","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ACI.0b013e32833aa54d","article-title":"Patch testing in drug allergy","volume":"10","author":"Friedmann","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ebm.13.6.162-a","article-title":"GRADE: assessing the quality of evidence for diagnostic recommendations","volume":"13","author":"Sch\u00fcnemann","year":"2008","journal-title":"Evid Based Med"},{"key":"10.1016\/j.jaip.2022.09.011_bib21","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"61","author":"Bossuyt","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaip.2022.09.011_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cod.12842","article-title":"Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests","volume":"77","author":"Assier","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.therap.2017.01.011","article-title":"Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs [in French]","volume":"72","author":"Ben Mahmoud","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.jaip.2022.09.011_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2015.07.014","article-title":"Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics","volume":"80","author":"Ben-Said","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2022.09.011_bib25","first-page":"70","article-title":"DRESS syndrome induced with the combination of vemurafenib and cobimetinib in melanoma: a series of 7 cases","volume":"31","author":"Bregeon","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2022.09.011_bib26","first-page":"425","article-title":"Piperacillin-induced DRESS: distinguishing features observed in a clinical and\u00a0allergy study of 8 patients","volume":"24","author":"Caba\u00f1as","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00228-011-1101-9","article-title":"Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?","volume":"68","author":"Daveluy","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.09.011_bib28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/bjd.17207","article-title":"Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases","volume":"180","author":"Ingen-Housz-Oro","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","article-title":"A\u00a0patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions","volume":"27","author":"Lin","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2022.09.011_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ced.12239","article-title":"Utility of patch testing for patients with drug eruption","volume":"39","author":"Ohtoshi","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib31","first-page":"53","article-title":"Long-term reproducibility of positive patch tests in nonimmediate cutaneous adverse drug reactions to antibiotics","volume":"75","author":"Pinho","year":"2016","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cod.12641","article-title":"Patch testing in the investigation of non-immediate cutaneous adverse drug reactions to metamizole","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cod.13462","article-title":"Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits","volume":"82","author":"Santiago","year":"2020","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib34","first-page":"27","article-title":"Are drug intradermal tests dangerous to explore cross-reactivity and co-sensitization in DRESS?","volume":"27","author":"Soria","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib35","article-title":"The absence of CYP3A5 3 is a protective factor to anticonvulsants hypersensitivity reactions: a case-control study in Brazilian subjects","volume":"10","author":"Tanno","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.09.011_bib36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex\u00a0vivo IFN-gamma release enzyme-linked immunoSpot assay and in\u00a0vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.011_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs -- an ENDA\/EAACI Drug Allergy Interest Group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.09.011_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing\u2014 recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40264-019-00825-2","article-title":"Mechanisms of severe cutaneous adverse reactions: recent advances","volume":"42","author":"Bell\u00f3n","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2022.09.011_bib40","first-page":"272","article-title":"Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity","volume":"29","author":"Houwerzijl","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib41","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2133.2005.06429.x","article-title":"The usefulness of skin tests to prove drug hypersensitivity","volume":"152","author":"Lammintausta","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/jdv.13796","article-title":"Patch testing\u2014a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics","volume":"31","author":"Pinho","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2022.09.011_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2018.10.030","article-title":"Controversies in drug allergy: testing for delayed reactions","volume":"143","author":"Phillips","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cod.12269","article-title":"Non-irritant concentrations and amounts of active ingredient in drug patch tests","volume":"71","author":"Brajon","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ad.2016.05.006","article-title":"Reactivation of skin lesions after patch testing to investigate drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"107","author":"C\u00f3rdoba","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaip.2022.09.011_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/cod.13733","article-title":"Reactivation of drug reaction with eosinophilia and systemic symptoms with ranitidine patch testing","volume":"84","author":"Teo","year":"2021","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjd.14492","article-title":"Diagnostic patch testing following tuberculosis-associated cutaneous adverse drug reactions induces systemic reactions in HIV-infected persons","volume":"175","author":"Lehloenya","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib48","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","article-title":"Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir","volume":"16","author":"Phillips","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2022.09.011_bib49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/529382","article-title":"High sensitivity of human leukocyte antigen-b\u22175701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients","volume":"46","author":"Saag","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2022.09.011_bib50","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1529-8019.2012.01409.x","article-title":"Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients","volume":"24","author":"Giorgini","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2022.09.011_bib51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A\u00a0multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.therap.2017.01.011","article-title":"Epicutaneous patch testing in delayed drug hypersensitivity reactions induced by antiepileptic drugs [in French]","volume":"72","author":"Ben Mahmoud","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.jaip.2022.09.011_bib53","first-page":"425","article-title":"Piperacillin-induced DRESS: distinguishing features observed in a clinical and allergy study of 8 patients","volume":"24","author":"Caba\u00f1as","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2022.09.011_bib54","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/bjd.17207","article-title":"Valaciclovir: a culprit drug for drug reaction with eosinophilia and systemic symptoms not to be neglected. Three cases","volume":"180","author":"Ingen-Housz-Oro","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib55","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2011.04418.x","article-title":"A\u00a0patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions","volume":"27","author":"Lin","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2022.09.011_bib56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ced.12239","article-title":"Utility of patch testing for patients with drug eruption","volume":"39","author":"Ohtoshi","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib57","first-page":"53","article-title":"Long-term reproducibility of positive patch tests in nonimmediate cutaneous adverse drug reactions to antibiotics","volume":"75","author":"Pinho","year":"2016","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cod.13462","article-title":"Hypersensitivity to antibiotics in drug reaction with eosinophilia and systemic symptoms (DRESS) from other culprits","volume":"82","author":"Santiago","year":"2020","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jaip.2017.09.004","article-title":"The combined utility of ex\u00a0vivo IFN-gamma release enzyme-linked immunoSpot assay and in\u00a0vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions","volume":"6","author":"Trubiano","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.09.011_bib61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cod.12842","article-title":"Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests","volume":"77","author":"Assier","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jdermsci.2015.07.014","article-title":"Allergic delayed drug hypersensitivity is more frequently diagnosed in drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome than in exanthema induced by beta-lactam antibiotics","volume":"80","author":"Ben-Said","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jaip.2022.09.011_bib63","first-page":"70","article-title":"DRESS syndrome induced with the combination of vemurafenib and cobimetinib in melanoma: a series of 7 cases","volume":"31","author":"Bregeon","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2022.09.011_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00228-011-1101-9","article-title":"Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?","volume":"68","author":"Daveluy","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2022.09.011_bib65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/cod.12641","article-title":"Patch testing in the investigation of non-immediate cutaneous adverse drug reactions to metamizole","volume":"76","author":"Pinho","year":"2017","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2022.09.011_bib66","first-page":"27","article-title":"Are drug intradermal tests dangerous to explore cross-reactivity and co-sensitization in DRESS?","volume":"27","author":"Soria","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2022.09.011_bib67","article-title":"The absence of CYP3A5 3 is a protective factor to anticonvulsants hypersensitivity reactions: a case-control study in Brazilian subjects","volume":"10","author":"Tanno","year":"2015","journal-title":"PLoS One"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822009461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:35:29Z","timestamp":1761975329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822009461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213219822009461"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.011","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.170667596.65309742\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.22541\/au.170668254.42329792\/v1","asserted-by":"object"}]},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility and Safety of Skin Tests in Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}